Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Generation Bio has raised $76.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2023.
Generation Bio's investors include Wellington Management, Foresite Capital, Moderna, Fidelity, Casdin Capital.
Generation Bio is headquartered in Cambridge, United States.
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Generation Bio is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Generation Bio — Funding & Investors." VCBacked, March 23, 2023, https://www.vcbacked.co/company/generation-bio. Accessed October 31, 2026.
VCBacked. (2023). Generation Bio — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/generation-bio
{{cite web |title=Generation Bio — Funding & Investors |url=https://www.vcbacked.co/company/generation-bio |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated